Chronic anal fissure
|
phenotype |
Digestive System Diseases
|
Acquired Abnormality
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anal sphincter hypertonia
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hypercholanemia
|
phenotype |
|
Finding
|
1
|
|
0.300 |
limited |
|
0 |
|
|
|
Arachnophobia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
3
|
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Hypercholanemia, Familial
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
3
|
0.710 |
None |
1.000 |
2 |
1
|
2003 |
2013 |
Fibroepithelioma of Pinkus
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Increased serum bile acid concentration
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Lipohypertrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
maternal hyperglycemia
|
disease |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hibernoma
|
disease |
Neoplasms
|
Neoplastic Process
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
von Willebrand Disease, Type 3
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
11
|
17
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Burning sensation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
30
|
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Intestinal metaplasia of gastric mucosa
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
35
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Oral infection
|
group |
Infections; Respiratory Tract Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
35
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
MSI-low
|
disease |
|
Neoplastic Process
|
37
|
2
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Steatorrhea
|
phenotype |
Digestive System Diseases; Nutritional and Metabolic Diseases
|
Finding
|
37
|
|
0.100 |
None |
|
0 |
|
|
|
von Willebrand Disease, Type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
39
|
26
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
T-Cell Prolymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
52
|
4
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Atypical Hemolytic Uremic Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
56
|
42
|
0.100 |
None |
|
0 |
2
|
|
|
Rickets
|
disease |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases
|
Disease or Syndrome
|
72
|
16
|
0.100 |
None |
|
0 |
|
|
|
Turcot syndrome (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms; Nervous System Diseases
|
Disease or Syndrome
|
77
|
75
|
0.010 |
None |
< 0.001 |
1 |
|
2008 |
2008 |
MSI-high
|
disease |
|
Neoplastic Process
|
83
|
9
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Invasive Lobular Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
88
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Osteogenesis Imperfecta
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases
|
Disease or Syndrome; Congenital Abnormality
|
90
|
91
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Subfertility
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
91
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |